Irrespective of how the phenotypes are caused, our data raises the possibility that neurodegeneration and memory loss in mouse models of AD may be prevented by targeting the Q/R site of GluA2, even in the presence of continuing Aβ-pathology. Here, GRIA2 is linked to Alzheimer disease.